Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-19T12:01:04.185Z Has data issue: false hasContentIssue false

6 - Androgens in postmenopausal women: Their practically exclusive intracrine formation and inactivation in peripheral tissues

from Section 2 - The scientific essentials

Published online by Cambridge University Press:  05 July 2015

By
Fernand Labrie
Edited by
Leo Plouffe, Jr  and
Botros R. M. B. Rizk
Leo Plouffe, Jr
Affiliation:
Bayer Healthcare, Wayne, New Jersey
Botros R. M. B. Rizk
Affiliation:
University of South Alabama
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Androgens in Gynecological Practice , pp. 64 - 73
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Labrie, F, Bélanger, A, Bélanger, P, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 2006;99(4–5):182–8.Google Scholar
2.Labrie, F. Intracrinology. Mol Cell Endocrinol 1991;78(3):C113–C8.Google Scholar
3.Labrie, F, Cusan, L, Gomez, JL, et al. Comparable amounts of sex steroids are made outside the gonads in men and women: strong lesson for hormone therapy of prostate and breast cancer. J Steroid Biochem Mol Biol 2009;113(1–2):52–6.CrossRefGoogle ScholarPubMed
4.Labrie, F, Martel, C, Balser, J. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary? Menopause 2011;18(1):30–43.Google Scholar
5.NAMS – The North American Menopause Society. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. Menopause 2005;12(5):496–511; quiz 649.Google Scholar
6.Rosner, W, Auchus, RJ, Azziz, R, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92(2):405–13.CrossRefGoogle ScholarPubMed
7.Rosner, W, Hankinson, SE, Sluss, PM, et al. Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab 2013;98(4):1376–87.Google Scholar
8.Taieb, J, Mathian, B, Millot, F, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 2003;49(8):1381–95.CrossRefGoogle ScholarPubMed
9.Moal, V, Mathieu, E, Reynier, P, et al. Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques. Clin Chim Acta 2007;386(1–2):12–19.Google Scholar
10.Sikaris, K, McLachlan, RI, Kazlauskas, R, et al. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab 2005;90(11):5928–36.CrossRefGoogle ScholarPubMed
11.Shackleton, C. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol 2010;121(3–5):481–90.CrossRefGoogle ScholarPubMed
12.Ke, Y., Bertin, J., et al. (2014). “A Sensitive, Simple and Robust LC-MS/MS Method for the Simultaneous Quantification of Seven Androgen- and Estrogen-Related Steroids in Postmenopausal Serum.” J Steroid Biochem Mol Biol 144: 523–534.Google Scholar
13.Ke, Y., Gonthier, R., et al. (2015). “A rapid and sensitive UPLC-MS/MS method for the simultaneous quantification of serum androsterone glucuronide, etiocholanolone glucuronide, and androstan-3alpha, 17beta diol 17-glucuronide in postmenopausal women.” JSBMB: In press.Google Scholar
14.Dury, A. Y., Ke, Y., et al. (2015). “Validated LC-MS/MS simultaneous assay of five sex steroid/neurosteroid-related sulfates in human serum.” JSBMB 149C: 1–10.Google Scholar
15.Labrie, F., Ke, Y., et al. (2015). “Why both LC-MS/MS and FDA-compliant validation are essential for accurate estrogen assays?” J Ster Biochem Mol Biol. 149C: 89–91.Google Scholar
16.Hsing, AW, Stanczyk, FZ, Belanger, A, et al. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev 2007;16(5):1004–8.CrossRefGoogle Scholar
17.Labrie, F. DHEA after menopause – sole source of sex steroids and potential sex steroid deficiency treatment. Menopause Management 2010;19:14–24.Google Scholar
18.Labrie, F, Labrie, C. DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Climacteric. 2013;16(2):205–13.Google Scholar
19.Labrie, C, Bélanger, A, Labrie, F. Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 1988;123(3):1412–17.CrossRefGoogle ScholarPubMed
20.Labrie, F, Dupont, A, Bélanger, A. Complete androgen blockade for the treatment of prostate cancer. In: de Vita, VT, Hellman, S, Rosenberg, SA, editors. Important Advances in Oncology. Philadelphia: J.B. Lippincott; 1985. pp. 193–217.Google Scholar
21.Labrie, F, Dupont, A, Bélanger, A, et al. New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen. Clin Invest Med 1982;5(4):267–75.Google Scholar
22.Crawford, ED, Eisenberger, MA, McLeod, DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989;321(7):419–24.CrossRefGoogle ScholarPubMed
23.Labrie, F, Bélanger, A, Cusan, L, et al. Antifertility effects of LHRH agonists in the male. J Androl 1980;1:209–28.Google Scholar
24.Baker, ME. Co-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors. Mol Cell Endocrinol 2004;215(1–2):55–62.Google Scholar
25.Labrie, F, Luu-The, V, Bélanger, A, et al. Is DHEA a hormone? Starling Review. J Endocrinol 2005;187(2):169–96.Google Scholar
26.Luu-The, V. Assessment of steroidogenic pathways that do not require testosterone as intermediate. Horm Mol Biol Clin Invest 2011;5:161–5.Google Scholar
27.Labrie, F, Simard, J, Luu-The, V, et al. Structure, function and tissue-specific gene expression of 3b-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J Steroid Biochem Mol Biol 1992;43(8):805–26.CrossRefGoogle Scholar
28.Labrie, F, Sugimoto, Y, Luu-The, V, et al. Structure of human type II 5α-reductase gene. Endocrinology 1992;131(3):1571–3.Google Scholar
29.Labrie, Y, Durocher, F, Lachance, Y, et al. The human type II 17β-hydroxysteroid dehydrogenase gene encodes two alternatively-spliced messenger RNA species. DNA Cell Biol 1995;14(10):849–61.Google Scholar
30.Luu-The, V, Zhang, Y, Poirier, D, et al. Characteristics of human types 1, 2 and 3 17b-hydroxysteroid dehydrogenase activities: oxidation-reduction and inhibition. J Steroid Biochem Mol Biol 1995;55(5–6):581–7.CrossRefGoogle Scholar
31.Labrie, F, Simard, J, Luu-The, V, et al. The 3β-hydroxysteroid dehydrogenase/isomerase gene family: lessons from type II 3β-HSD congenital deficiency. Signal Transduction in Testicular Cells, Ernst Schering Research Foundation Workshop 1996;Suppl. 2:185–218.Google Scholar
32.Labrie, F, Luu-The, V, Lin, SX, et al. The key role of 17b-HSDs in sex steroid biology. Steroids 1997;62(1):148–58.Google Scholar
33.Longcope, C, Franz, C, Morello, C, et al. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 1986;8(3):189–96.Google Scholar
34.Burger, HG, Dudley, EC, Cui, J, et al. A prospective longitudinal study of serum testosterone dehydroepiandrosterone sulfate and sex hormone binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85(8):2832–8.Google Scholar
35.Rannevik, G, Jeppsson, S, Johnell, O, et al. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995;21(2):103–13.CrossRefGoogle ScholarPubMed
36.Labrie, F. Drug Insight: breast cancer prevention and tissue-targeted hormone replacement therapy. Nat Clin Pract Endocrinol Metab 2007;3(8):584–93.Google Scholar
37.Labrie, F, Luu-The, V, Labrie, C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003;24(2):152–82.Google Scholar
38.Labrie, F, Bélanger, A, Cusan, L, et al. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82(8):2396–402.Google Scholar
39.Luu-The, V, Labrie, F. The intracrine sex steroid biosynthesis pathways. In: Martini, L, Chrousos, GP, Labrie, F, et al., editors. Neuroendocrinology, Pathological Situations and Diseases, Progress in Brain Research: Elsevier; 2010. pp. 177–92.Google Scholar
40.Couzinet, B, Meduri, G, Lecce, MG, et al. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 2001;86(10):5060–6.Google Scholar
41.Abraham, GE, Lobotsky, J, Lloyd, CW. Metabolism of testosterone and androstenedione in normal and ovariectomized women. J Clin Invest; 1969;48(4):696–703.CrossRefGoogle ScholarPubMed
42.Jabara, S, Christenson, LK, Wang, CY, et al. Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J Clin Endocrinol Metab 2003;88(1):484–92.Google Scholar
43.Cauley, JA, Gutai, JP, Kuller, LH, et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129(6):1120–31.CrossRefGoogle ScholarPubMed
44.Nagamani, M, Urban, RJ. Expression of messenger ribonucleic acid encoding steroidogenic enzymes in postmenopausal ovaries. J Soc Gynecol Investig 2003;10(1):37–40.Google Scholar
45.Havelock, JC, Rainey, WE, Bradshaw, KD, et al. The post-menopausal ovary displays a unique pattern of steroidogenic enzyme expression. Hum Reprod 2006;21(1):309–17.Google Scholar
46.Spark, RF. Dehydroepiandrosterone: a springboard hormone for female sexuality. Fertil Steril 2002;77 Suppl 4:S19–25.CrossRefGoogle ScholarPubMed
47.Zumoff, B, Strain, GW, Miller, LK, et al. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995;80(4):1429–30.Google Scholar
48.Basson, R. A new model of female sexual desire. Endocrine News. 2004;29:22.Google Scholar
49.Tchernof, A, Labrie, F. Dehydroepiandrosterone, obesity and cardiovascular disease risk. A review of human studies. Eur J Endocrinol 2004;151(1):1–14.Google Scholar
50.Shifren, JL, Braunstein, GD, Simon, JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343(10):682–8.CrossRefGoogle ScholarPubMed
51.Sherwin, BB, Gelfand, MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987;49(4):397–409.Google Scholar
52.Cameron, DR, Braunstein, GD. Androgen replacement therapy in women. Fertil Steril 2004;82(2):273–89.Google Scholar
53.Garland, CF, Friedlander, NJ, Barrett-Connor, E, et al. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 1992;135(11):1220–30.Google Scholar
54.Leiblum, S, Bachmann, G, Kemmann, E, et al. Vaginal atrophy in the postmenopausal women. The importance of sexual activity and hormones. JAMA 1983;249(16):2195–8.Google Scholar
55.Lipworth, L, Adami, HO, Trichopoulos, D, et al. Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 1996;7(1):96–100.CrossRefGoogle ScholarPubMed
56.Davis, SR, McCloud, P, Strauss, BJ, et al. Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality. Maturitas 1995;21(3):227–36.CrossRefGoogle ScholarPubMed
57.Labrie, F, Bélanger, A, Cusan, L, et al. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 1997;82(8):2403–9.CrossRefGoogle Scholar
58.Poortman, J, Thijssen, JH, von Landeghem, AA, et al. Subcellular distribution of androgens and oestrogens in target tissue. J Steroid Biochem 1983;19(1C):939–45.Google Scholar
59.Bélanger, B, Bélanger, A, Labrie, F, et al. Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. J Steroid Biochem 1989;32(5):695–8.Google Scholar
60.Bélanger, A, Pelletier, G, Labrie, F, et al. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 2003;14(10):473–9.Google Scholar
61.Zwicker, H, Rittmaster, RS. Androsterone sulfate: physiology and clinical significance in hirsute women. J Clin Endocrinol Metab 1993;76(1):112–16.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×